Workshop on regulatory aspects of atrial fibrillation
Londres, 15-16 de septiembre de 2009

Topic 1
Pharmacological cardioversion - what constitutes cardioversion (and recurrence)?
Juan Tamargo

Topic 2
Is the underlying aetiology of atrial Fib/Fl iimportant?
Juan Tamargo

Programa